Baxfendy

News

AstraZeneca is the first company to get FDA approval for an aldosterone synthase inhibitor for hypertension, ahead of rival Mineralys.

Oncology

Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.